Presentation is loading. Please wait.

Presentation is loading. Please wait.

Kaplan-Meier survival curves of the IMRS association with non-fatal stroke/mortality (stroke-free survival) in women with AF, stratified by CHA2DS2-VASc.

Published byBlaze Watts Modified over 4 years ago

Similar presentations

Presentation on theme: "Kaplan-Meier survival curves of the IMRS association with non-fatal stroke/mortality (stroke-free survival) in women with AF, stratified by CHA2DS2-VASc."— Presentation transcript:

1 Kaplan-Meier survival curves of the IMRS association with non-fatal stroke/mortality (stroke-free survival) in women with AF, stratified by CHA2DS2-VASc score of (A) 1 (p-trend <0.001, IMRS<9: n=251, 9–14: n=97, ≥15: n=9), (B) 2 (p-trend <0.001, IMRS<9: n=3... Kaplan-Meier survival curves of the IMRS association with non-fatal stroke/mortality (stroke-free survival) in women with AF, stratified by CHA2DS2-VASc score of (A) 1 (p-trend <0.001, IMRS<9: n=251, 9–14: n=97, ≥15: n=9), (B) 2 (p-trend <0.001, IMRS<9: n=312, 9–14: n=296, ≥15: n=40) and (C) >2 (p-trend <0.001, IMRS<9: n=433, 9–14: n=1736, ≥15: n=948). IMRS, Intermountain Mortality Risk Score. Kevin G Graves et al. Open Heart 2018;5:e000907 ©2018 by British Cardiovascular Society

Download ppt "Kaplan-Meier survival curves of the IMRS association with non-fatal stroke/mortality (stroke-free survival) in women with AF, stratified by CHA2DS2-VASc."

Similar presentations

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Oncol Res Treat 2016;39: DOI: /

Oncol Res Treat 2016;39: DOI: /
 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.
Circ Cardiovasc Interv

Circ Cardiovasc Interv
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.

Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.
CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,
Impact of risk factors and age of initiation of therapy on the distribution of lifespan gain. ‘National average risk’ refers to a cohort beginning at age.

Impact of risk factors and age of initiation of therapy on the distribution of lifespan gain. ‘National average risk’ refers to a cohort beginning at age.
Fung TT, et al. Circulation 2009;119:

Fung TT, et al. Circulation 2009;119:
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Receiver operating curves (ROC) of the Framingham and QRISK2 risk factor models for predicting 10-year risk of cardiovascular disease with and without.

Receiver operating curves (ROC) of the Framingham and QRISK2 risk factor models for predicting 10-year risk of cardiovascular disease with and without.
Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
Volume 7, Issue 11, (November 2010)

Volume 7, Issue 11, (November 2010)
Enrollment and Outcomes

Enrollment and Outcomes
(A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the recalibrated model on the external validation set data. (A)

(A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the recalibrated model on the external validation set data. (A)
Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.

Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.
Volume 16, Issue 1, Pages 3-9 (January 2019)

Volume 16, Issue 1, Pages 3-9 (January 2019)

Similar presentations

Ads by Google